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Relevance. Benign prostatic hyperplasia (BPH) is one of the most common diseases in 
older men age. In the course of the trial treatment of such pathology is impossible due to a 
number of objective reasons, such as age and severe concomitant diseases impossible 
surgical methods of treatment. 
 
Goal. Evaluate the effectiveness and safety of a minimally invasive method embolization 
of the prostatic arteries (PAE) at large volumes Benign prostatic hyperplasia in patients 
with severe concomitant pathologies. 
Materials and methods. From August 2012 to May 2018, the PAE completed 
42 patients with BPH. Patients were included in this group wich the operation was 
contraindicated or undesirable due to high surgical and anesthetic risks. The age of patients 
ranged from 58 up to 86 years, an average of 67 years. Patients had a severe competing 
pathology (cardiac ischemia, postinfarction cardiosclerosis, heart rhythm disturbances, 
arterial hypertension, diabetes mellitus, Acute disorders of cerebral circulation in the 
anamnesis). 62% of patients were overweight body. Attempts to endovascular occlusion of 
the arterial bed of the prostate were 89%. In three patients unsuccessful cannulation 
attempts related to age of the iliac arteries. 50-60 years, 2 patients (4.7%), 60-70 years - 19 
of patients (45.2%), 70-80 years - 18 patients (42.8%), 80-90 years - 3 patients (7.1%). As 
an embolizing agent, microspheres of 300-500 microns. In 37 cases, a microcatheter 
technology (super selective embolization), microcatheters Embocath, Maerstro, Progreat. 
Complications in the postoperative course to us was avoided. 
Results. Short-term results of treatment were evaluated by us on a common complaints of 
patients, assessment of symptoms of the lower urinary tract by scale of IPSS, reduction in 
prostate volume and the amount of residual urine. In the short-term period, 1 month after 
treatment, a positive dynamics of key indicators. The volume of the prostate, according to 
TRUS, before surgery an average of 86 mm
3
, and after surgery an average of 47 mm
3
 
(54.7% from the original). According to ultrasound, the volume of residual urine before the 
intervention was from 120 to 315 ml, an average of 217.5 ml. In a control study in a month 
the volume of residual urine decreased to an average of 50 ml (60.7% of the baseline level). 
It should also be noted positive subjective feedback from patients improvement 
urodynamics, reducing the number of night calls to urination. Three patients were 
performed against a ackground of acute retention of urine. The operation was performed 
against a background of permanent catheterization. Have one of them in an early 
postoperative study independent urination. The other two need to perform an operation for 
the time of urine derivation - epicystostomy, independent urination in them was restored in 
1 and 1,5 months. after the interference. The QoL quality of life index also has changed 
positively.  
Conclusion: Embolization of the prostatic arteries is relatively safe and effective treatment 
for BPH and an alternative for surgical treatment in patients with high operating and 
anesthetic risk. 
 
 
 
 
